Preliminary treatment results of liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2B and ribavirin using combination pegylated interferon alpha 2B with ribavirin.

被引：0
|
作者：
Neff, GW
Montalbano, M
Lee, YM
Slapak, G
Safdar, K
Morrero, R
Nery, J
Weppler, D
Demodina, M
Schiff, E
Tzakis, A
机构：
[1] Univ Miami, Sch Med, Div Hepatol, Miami, FL 33152 USA
[2] Univ Miami, Sch Med, Div Surg, Miami, FL 33152 USA
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
68
引用
收藏
页码：183A / 183A
页数：1
相关论文
共 50 条
  • [1] Preliminary treatment results of pegylated interferon alpha 2b and ribavirin in liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2b and ribavirin
    Neff, GW
    Montalbano, M
    Ozden, N
    Muslu, H
    Lee, YM
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Madariaga, J
    Levi, D
    Nashida, S
    Kato, T
    Schiff, E
    Tzakis, A
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 160 - 160
  • [2] Interferon Alpha 2b in Combination with Ribavirin as a Treatment for Chronic Hepatitis C
    Mandokhel, Sherbet Khan
    Aziz-U-Rehman
    Khan, Mohammad Saleem
    Azeemullah
    [J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (01): : 168 - 171
  • [3] Treatment with combination peginterferon alfa-2b and ribavirin of recurrent hepatitis C in liver transplant recipients nonresponsive to interferon alfa-2b and ribavirin
    Samanta, A
    Mandalapu, A
    Fisher, A
    Wilson, D
    de la Torre, A
    Klein, KM
    Koneru, B
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A455 - A456
  • [4] Combination of interferon alfa 2b and ribavirin in liver transplant recipients with histologic recurrent hepatitis C
    Firpi, RJ
    Nelson, DR
    Soldevila, C
    Abdelmalek, MF
    Reed, A
    Hemming, A
    Howard, R
    Van der Werk, W
    Lauwers, G
    Davis, GL
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A93 - A93
  • [5] Naive treatment results in liver transplant recipients with hepatitis C virus recurrence (HCV-R) using pegylated interferon alpha-2B combined with ribavirin. Preliminary results.
    Neff, G
    Montalbano, M
    Lee, YM
    Slapak, G
    Safdar, KM
    Morrero, R
    Nery, J
    Weppler, D
    De Modina, M
    Schiff, E
    Tzakis, A
    [J]. HEPATOLOGY, 2002, 36 (04) : 183A - 183A
  • [6] Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C
    Poynard, T
    [J]. GUT, 2003, 52 (10) : 1532 - 1532
  • [7] Triple combination of pegylated interferon alpha 2b, ribavirin and amantadine for treatment of chronic hepatitis
    Younossi, ZM
    McCullough, AJ
    Barnes, DS
    Post, A
    Ong, JP
    Mullen, KD
    Carey, WD
    O'Shea, R
    Levinthal, G
    Gramlich, T
    Martin, LM
    Bringman, D
    Tavill, A
    Ferguson, R
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A781 - A781
  • [8] Treatment of recurrent hepatitis C after liver transplantation with alpha-2B interferon plus ribavirin.
    Ghalib, R
    Pandula, R
    Kadhim, TJ
    Clark, C
    Ankoma-Sey, V
    Fouzia, S
    Stribling, RJ
    Goss, JA
    Seu, P
    [J]. HEPATOLOGY, 2000, 32 (04) : 291A - 291A
  • [9] Pegylated interferon α-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C
    Ross, AS
    Bhan, AK
    Pascual, M
    Thiim, M
    Cosimi, AB
    Chung, RT
    [J]. CLINICAL TRANSPLANTATION, 2004, 18 (02) : 166 - 173
  • [10] Combination pegylated interferon alpha-2b and ribavirin in transplant patients with recurrent hepatitis C infection: A preliminary report.
    Vargas, HE
    Rosati, MJ
    Douglas, DD
    Harrison, ME
    Mulligan, DC
    Moss, AA
    Rakela, J
    Balan, V
    [J]. HEPATOLOGY, 2001, 34 (04) : 407A - 407A
12345